Why We Are Top

For more than 30 years, TopRx has been a leader in the generic pharmaceutical industry focused on serving customers by creating a superior customer experience. We are committed to offering competitively priced generic pharmaceuticals while providing exceptional service to our valued pharmacy customers. That is not where it stops. We offer preferred brand pharmaceuticals, over the counter products, PPE, antidiabetic products as well as medical products and vials for pharmacy fulfillment. We are “Tops” in our field at looking at ourselves to better serve you by establishing a comprehensive portfolio of products to exceed your expectations.

Learn More

Our Mission.

At TopRx, our mission is to provide personalized solutions and outstanding customer support within the pharmaceutical industry. We build strong relationships with our partners by being honest, professional, transparent, and reliable. We pride ourselves on saving you time and money, in being your go to supplier. Equipped with the most up-to-date information and knowledge of industry trends, TopRx is your pharmaceutical partner focused primarily on generics and preferred brands along with other over the counter products, every step of the way!

Learn More

Ordered.  Shipped.  On Time.

TopRx understands that your clients and patients demand the best care. That’s why you need a pharmaceutical distributor you can depend on. When you choose TopRx, you can order with confidence knowing that your shipments are safely handled, professionally packed, and ready to meet your demands. Orders placed before 9 p.m. ET are shipped for next-day delivery and will arrive with a 99.9% accuracy rate.

Learn More

Customer led.  Industry driven.

If you think all pharmaceutical distributors are alike, it’s time to think again. At TopRx, we focus on providing key products and services to our pharmacy partners. We take the time to learn your business and will recommend the most efficient solution based on your needs. From pricing to products, we are leaders in the pharmaceutical industry in service, quality, and customer service. At TopRx, we deliver on our word. We want to help you be on “Top” of your performance.

Learn More

Our Service Is “Top” Notch.

We are an authorized distributor of record (ADR) for all major manufacturers and licensed to ship to all 50 states. We have earned accreditation by the National Association of Boards of Pharmacy (NABP) and are compliant with all Drug Supply Chain Security Act (DSCSA) regulations. TopRx is a proud member of the National Community Pharmacy Association (NCPA), National Association of Chain Drug Stores (NACDS), and Healthcare Distribution Alliance (HDA).

Learn More


Nature’s Bounty has chosen a retail veteran to join its team as chief communications officer. Amy von Walter, most recently executive vice president of global communications and customer care for Toys “R” Us, will lead the Ronkonkoma, N.Y.-based company’s external and internal communications, as well as its government affairs and corporate social responsibility efforts, reporting to president and CEO Paul Sturman. “Amy is a seasoned communications leader with a proven track record,” Sturman said. “I am confident that her experience, coupled with her energy and collaborative approach, will help us achieve our ambitious goals for growth and further build on the culture here at Nature’s Bounty.”
BioNTech AG, a biotechnology company focused on precise immunotherapies for the treatment of cancer and infectious disease has entered into a multi-year research and development (R&D) collaboration with Pfizer to develop mRNA-based vaccines for prevention of influenza. “Today’s agreement with Pfizer is one of a number of steps that we are taking to rapidly build a sustainable R&D presence in infectious disease, combining our deep understanding of the immune system to treat disease with the cutting-edge technologies and significant infrastructure that we have built-up over many years to develop immunotherapy treatments,” BioNTech co-founder and CEO Ugur Sahin, said, in a press statement. “A significant presence in infectious disease supports our goal of building a global immunotherapy company that provides more effective and precise immune-mediated approaches for the prevention and treatment of serious illnesses, such as the prevention of flu and the treatment of cancer.”
Lannett announced earlier this week that its distribution agreement with Jerome Stevens Pharmaceuticals (JSP), which expires on March 23, 2019, will not be renewed. “The Steinlauf family advised us this past Friday evening that they will not renew our agreement to distribute three JSP products: butalbital, aspirin, caffeine with codeine phosphate capsules USP, digoxin tablets USP and levothyroxine sodium tablets USP, upon its expiration in March 2019,” Tim Crew Lannett’s CEO, said. “The family has assured us of a continuous supply of the products through March of next year. These products remain valuable assets for us and are expected to significantly contribute to our financial performance in fiscal 2019.